Home LiteratureArticle Details
PMID: 25537147 Published · ppublish English

Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.

Clinical and experimental medicine ·Vol. 16 ·No. 1 ·2016-10-21

Shadrina Alexandra S, Ermolenko Natalia A, Boyarskikh Uljana A, Sinkina Tatiana V, Lazarev Alexandr F, Petrova Valentina D, Filipenko Maxim L

Abstract

Genetic variation in DNA repair genes can alter an individual's capacity to repair damaged DNA and influence the risk of cancer. We tested seven polymorphisms in DNA repair genes XRCC1, ERCC2, XRCC3, XRCC2, EXOI and TP53 for a possible association with breast cancer risk in a sample of 672 case and 672 control Russian women. An association was observed for allele A of the polymorphism XRCC1 (R399Q) rs25487 (co-dominant model AA vs. GG: OR 1.76, P = 0.003; additive model OR 1.28, P = 0.005; dominant model: OR 1.29, P = 0.03; recessive model OR 1.63, P = 0.008). Allele T of the polymorphism ERCC2 (D312N) rs1799793 was also associated with breast cancer risk (co-dominant model TT vs. CC: OR 1.43, P = 0.04; additive model OR 1.21, P = 0.02; dominant model: OR 1.30, P = 0.02), but the association became insignificant after applying Bonferroni correction. No association with breast cancer was found for the remaining SNPs. In summary, our study provides evidence that polymorphisms in DNA repair genes may play a role in susceptibility to breast cancer in the population of ethnical Russians.

Keywords
Breast cancer DNA repair Russian population SNP
Article Info
Journal
Clinical and experimental medicine
Abbr.
Clin Exp Med
Published
2016-10-21
Indexed
2016-02-09
Updated
2016-10-22
Language
English
Country/Region
Italy
NLM ID
100973405
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com